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Knowledge Transfer Statement: 
Data from qualitative interviews conducted with patients with persistent orofacial pain 
suggests significant problems with the existing care pathway consisting of delays to 
diagnosis, treatment and referral. Patients describing the struggle to progress through the 
current care pathway highlighted the difficulties occurring while living with orofacial pain. This 
study suggests a need for a revised care pathway, which better meets the needs of people 
with persistent orofacial pain. 
 
Abstract:  
Persistent orofacial pain is relatively common and known to have an adverse effect on 
quality of life. Previous studies suggest that the current care pathway may be problematic 
but it is not well understood which health services patients access and their experience of 
this. The aim of this study was to explore care pathways and their impact from the 
perspective of patients. Qualitative interviews were conducted with a maximum variation 
sample of patients recruited from primary (community-based) and secondary (specialist 
hospital based) care in the UK. Questions focussed on the stages in their pathway and the 
impact of the care they had received. Interviews were digitally recorded and transcribed 
verbatim and analysis followed principles of the constant comparative method. NVivo 10 was 
used to help organise and analyse data. Twenty-two patients were interviewed at Baseline 
and 18 took part in a second interview at 12 months. Three main themes emerged from the 
data: the ‘fluidity of the care pathway’, in which patients described moving between different 
healthcare providers in attempts to have their pain diagnosed and managed, occurring 
alongside a ‘failure to progress’, where, despite multiple appointments patients described 
frustration at delays in obtaining a diagnosis and effective treatment for their pain. 
Throughout their care pathways patients described the ‘effects of unmanaged pain’ where 
the longer pain went unmanaged the greater its potential to negatively impact on patients’ 
lives. Findings of this study suggest that the current care pathway is inefficient and fails to 
meet patient needs. Future work needs to focus on working with stakeholder groups to 




Persistent orofacial pain refers to a group of chronic disorders affecting the face and mouth 
and includes: Temporomandibular Disorders (TMD), Burning Mouth Syndrome, Trigeminal 
Neuralgia (TN) and Persistent Dentoalveolar Pain Disorder (PDAP), and Persistent 
Idiopathic Facial Pain (Benoliel and Sharav 2010). Persistent orofacial pain is relatively 
common, affecting 7% of the UK population (Aggarwal et al. 2010) and is known to cause 
substantial impacts on quality of life (John et al. 2006; Shueb et al. 2015) . Despite its 
prevalence there is a limited understanding of patients’ experiences of persistent orofacial 
pain and the impact it has on their everyday lives. The small amount of qualitative data 
present in the literature - focusing on persistent orofacial pain collectively (Mohr et al. 2011; 
Wolf et al. 2006; 2008) and on singular specific persistent orofacial pain conditions (Durham 
et al. 2012; Durham et al. 2010; Hakeberg et al. 2003; Peters et al. 2005) - suggests multiple 
impacts on several areas of a person’s life including social, emotional and financial aspects 
of everyday life. Some of the same research also highlights that patients experience 
difficulties in communicating their pain to doctors, potentially leading to problematic 
relationships (Durham et al. 2012; Mohr et al. 2011; Wolf et al. 2008).  However, there has 
been no longitudinal concurrent quantitative and qualitative examination of patients’ costs 
and experiences during their journey in a care pathway for persistent orofacial pain i.e. a 
concurrent “quan-qual” approach to understanding care pathways better  (Durham et al. 
2016; Morgan 1998). 
Management of persistent orofacial pain spans both medicine and dentistry and multiple 
specialities and, in common with other chronic pain disorders, requires a multidisciplinary 
approach to management (Madland and Feinmann 2001). Madland and Feinmann (2001) 
hypothesise that the location of orofacial pain may be a barrier to its management; 
suggesting that while the location of the pain implies the requirement of dental services, the 
pain may share qualities with other medical chronic illnesses which need more than one 
clinical speciality or profession’s input. This may represent a problem for patients, however, 
as both medical and dental practitioners have expressed substantial uncertainty about how 
to manage persistent orofacial pain when it presents to them (Aggarwal et al. 2011a; 
Durham et al. 2007; Durham et al. 2011; Peters et al. 2015) and there are few services 
available to provide specialist advice on management (Aggarwal et al. 2011a). 
Patients with persistent orofacial pain are known to use more healthcare services compared 
to other groups of patients (White et al. 2001) which often includes multiple consultations 
and diagnostic tests (Glaros et al. 1995).   Durham et al’s study of TMD care suggests that 
some of this increased healthcare resource utilisation may be accounted for by inadequate 
care pathways resulting in cyclical referrals and unnecessary consultations (Durham et al, 
2011). This finding is supported by recently published data (Peters et al. 2015) suggesting 
that both patients and healthcare professionals find persistent orofacial pain difficult and 
frustrating to manage.  Despite these data there is limited understanding of how and why 
patients access healthcare services over the longer-term management of their condition and 
their longitudinal experiences of this care pathway.  This paper seeks to address this gap in 
knowledge by critically examining patients’ use, and experience, of healthcare for persistent 
orofacial pain over a twelve month period and link this to the recently published cost analysis 
(quantitative data from the concurrent quan-qual approach of the DEEP study) from the 





The aim of this qualitative study was to critically examine patients’ journeys through care and 
identify their experiences of the care pathway and use these findings to help explain some of 
the findings in the cost analysis of the care pathways that ran concurrent to this sub-study 
(Durham et al. 2016). 
Study Design  
The DEEP study’s (Developing Effective and Efficient care pathways for patients with 
chronic Pain http://research.ncl.ac.uk/deepstudy) full protocol is available online in open 
access format  (Durham et al. 2014) so a full description of the study will not be given, but 
briefly the aim of the DEEP study was to use mixed-methods in order to describe and 
understand current care pathways for persistent orofacial pain patients and identify areas 
where the current pathways could be improved. Following ethical approval (NHS Research 
Ethics Committee NRES Reference: 12/YH/0338) serial quantitative data using validated 
self-complete instruments were collected from patients with persistent orofacial pain in the 
North-East of England at six monthly intervals: quality of life (EQ-5D (Herdman et al. 2011)), 
multidimensional pain experience ([West-Haven Yale] Multidimensional Pain Inventory and 
Graded Chronic Pain scale (Kerns et al. 1985; Von Korff et al. 1992)), Illness perceptions 
(Illness perceptions questionnaire IPQ-R  (Moss-Morris et al. 2002)), anxiety and depression 
(PHQ-4 (Kroenke et al. 2009)) and use of services and productivity (Wordsworth and 
Thompson 2001). The first paper from this study, examining costs and their predictors has 
recently been published (Durham et al. 2016) and this paper refers to, and helps explain, 
some of those quantitative findings. 
Mixed methods research has gained in popularity recently helping to explain more complex 
problems in healthcare (Tariq and Woodman 2013) and in the context of this study it was 
anticipated that qualitative data would complement and give greater context to the 
quantitative data collected. This qualitative study is an example of longitudinal qualitative 
research (Calman et al. 2013), in which qualitative data was gathered at multiple time points 
and the qualitative approach thereby allowed patients time: to explain their experiences of 
care, elaborate on their patterns of service utilisation and the impact of the current care 
pathway. A longitudinal approach to qualitative data collection was particularly appropriate in 
the context of this study’s aim as it allowed: the collection of data over time, examination of 
transitions in care, and examination of the stability of concepts or constructs patients 
explained at different points in time (Calman et al. 2013).  
Prior to joining the DEEP study all patients (n=198) completed a screening questionnaire to 
identify the most likely origin of their pain (musculoskeletal, neurovascular/pathic or 
combined origin) and provided written informed consent. Patients then provided a detailed 
structured history of their pain including: duration of pain; diagnosis received; healthcare 
professionals visited; number of appointments and medications or treatments provided. 
Following this, for the purposes of the current paper, a purposive maximum variation sub-
sample of those participating in the DEEP study was taken based on gender, care 
environments experienced, time in care, and origin of persistent orofacial pain. 
This sub-sample was recruited in the first six months of patients enrolling in the DEEP study. 
Two experienced and trained interviewers (MB and SB) conducted these semi-structured 
interviews by telephone (with the exception of two, where at the patient’s request, interviews 
took place face to face on university premises). While telephone interviews can be viewed 
less favourably to face to face interviews, it has also been suggested that the two 
approaches obtain similar results (Sturges and Hanrahan 2004), with some even suggesting 
that telephone interviews may offer some advantages in causing respondents to relax more 
and disclose sensitive information (Novick 2008). 
The initial topic guide for the interviews was informed by previous research (Durham et al. 
2012; Durham et al. 2010) and questions focused on the experience of using healthcare 
services since the interviewee’s pain began. The topic guide focused on: the nature and 
impact of pain, use of health services, information received, and if care could have been 
improved. The topic guide was flexible, enabling new topics to be explored as they emerged, 
and the guide evolved as themes emerged from interviews. Changes to the topic guide were 
discussed regularly among the research team and data collection continued until saturation. 
The longitudinal design of the qualitative study meant that interviews were repeated at 12 
months using the same topic guide but with additional questions added that were designed 
to further explore themes arising at baseline from both the qualitative and quantitative data. 
Data analysis 
This research followed best practice for mixed-methods research (Creswell et al. 2011). The 
analytic approach used iterative thematic analysis (Rapley and Silverman 2011). It follows 
the SRQR standards for reporting qualitative research (O’Brien et al. 2014). Interviews were 
digitally recorded and transcribed verbatim. Immersion in the data began with an initial 
reading of the transcripts whilst listening to the recording; this served to familiarise the 
researchers with the data and identify transcription errors or missing data. The two 
interviewers carried out coding of data and regular discussion of emerging themes took 
place at project team meetings. Data from baseline and twelve months were treated 
identically with respect to coding and identification of themes but pairs of interviews were 
also examined together in order to examine experiences in the period between the two 
interviews. Care pathways for each patient were assembled based on interview data 
consistent with methodology previously reported by the research team (Durham et al. 2011). 
NVivo qualitative data analysis software (QSR International Pty Ltd. Version 10, 2012) was 
used to help organise and analyse the data.  
  
Results 
Twenty-two patients who had experienced persistent orofacial pain for between 3 months 
and 27 years were interviewed at baseline. Interviews were repeated twelve months later 
with 18 of these participants. Reasons for dropout at twelve months were non-response 
(n=3), and health issues unrelated to persistent orofacial pain (n=1). Participant 
characteristics are summarised in Table 1 along with those who dropped out. Presentation of 
data below is structured according to the three major themes to emerge from the data: 
‘Fluidity of care pathway’;  ‘Failure to progress’; ‘Impact of unmanaged pain’. Patients’ 
quotes are used throughout the results in order to illustrate findings and the parentheses 
following the quote contain patient’s qualitative study numbers and the time of contact 
(baseline or twelve months). Although patients talked extensively about the experience of 
their pain, this paper will focus primarily on the care pathway itself. 
 
Fluidity of care pathway 
One of the major themes in these interviews related to the movement of patients between 
different healthcare professionals and settings in an attempt to obtain a diagnosis and 
effective treatment for their pain. 
Patients reported that their first contact with the health service was usually through their 
General Dental Practitioner or General Medical Practitioner (GP). Patients chose to seek 
help from either a General Dental Practitioner or GP based on whether they perceived their 
pain to originate in their teeth/jaw or elsewhere. Formal referral pathways or processes 
between GP and General Dental Practitioners were not evident in the data, but there were 
sporadic reports of GPs suggesting patients discuss with their dentists and vice versa. This 
tended to occur when a Healthcare Professional suspected that the cause of pain was 
outside their professional remit:  
“he [General Dental Practitioner] went ‘No’, you’ve got trigeminal neuralgia 
you need to go and see your  GP.’” (Q13, Baseline Interview)   
In some cases where the diagnosis or origin of pain remained unclear, patients continued to 
seek help from both dental and medical services: 
 “I’ve been to see them all [dental and medical professionals]. The GPs don’t seem to 
know what to do. I just don’t know where to go next. I go to GPs and they just give 
me more tablets and that’s it.” (Q12, 12M interview) 
The referral process from primary care to secondary care seemed to vary greatly between 
patients; although a minority of referrals happened quickly for some, other patients described 
a long delay or even a reluctance to refer to a specialist in secondary care. Some patients 
who reported that they had not received effective management in primary care felt that their 
case was not being prioritised, or that their primary care practitioner did not appreciate the 
severity of their pain:  
 “I think you know migraines clearly isn’t [sic, aren’t] life threatening is it so you’re 
kind of back to the back of the queue in a way.“ (Q5, Baseline Interview) 
“I mean you go to the doctor [GP], they don’t know what pain you are in, they can’t 
feel it, nobody can feel the pain you’re in. As far as the doctor was concerned, he 
was giving me something, it was for fits [epilepsy] or something, Tegretol, I don’t 
know what is for, it’s not for neuralgia, but it’s for facial pain…. He gave me them and 
he didn’t send me to anyone, so that’s how bad it was, he didn’t send me anywhere 
[for further treatment] so you can work that one out yourself, you know, whether it’s, 
whether they’re bothering or not [to take the problem seriously]…the dentist bothered 
more than the doctor but he [the dentist] couldn’t see nothing wrong with me”. (Q14, 
Baseline Interview). 
 
Following a number of appointments without effective treatment, many patients felt that the 
next step should be a referral to a specialist, and they became frustrated when this did not 
happen. Several reported the need to emphasise the seriousness of their pain or insist on a 
specific course of action such as referral to a specialist:  
“I actually went to my GP … I had the confidence to do that, a lot of people don’t…[I] 
said you know it’s just getting…, you know I can’t live with this at the moment, and 
should I be referred to a neurologist” (Q5, Baseline Interview) 
Whilst many people described a situation in primary care in which they struggled to receive a 
diagnosis, pain management or a referral, a small group of patients described their 
experience more positively. This group of patients had several factors in common: they had 
received effective treatment relatively quickly from their GP; they described a positive 
relationship with their GP in which they trusted their ability to manage their condition; they 
could easily access their GP:  
“I have faith in them [the GP] and, and they’re good in that they listen and 
they act on what you say in that they’ve never kind of gone oh you’re talking 
rubbish about anything.” (Q13, Baseline Interview).   
 
Patients who were referred to secondary care reported being sent to a range of different 
departments in medical and dental hospital. For example: neurology, pain clinics, oral 
surgery, ear nose and throat surgery, physiotherapy, ophthalmology, maxillofacial surgery 
and haematology. For some, secondary care was the first time they had received a 
diagnosis for their pain, others received confirmation of a suspected primary care diagnosis 
and some reported contradictory diagnoses from secondary care healthcare professionals. 
Those who received treatment in secondary care reported a range of treatments: new or 
revised pain medication prescriptions, dental splints, exercises and in some cases surgery. 
A number received further referrals to other specialisms within secondary care and others 
were prescribed pain medication which was subsequently managed longer-term within 
general practice.   
Some patients received treatment in secondary care, which had a positive effect on the level 
of pain:  
“he [the consultant] made me a mould thing [splint], that I wear at night, and that’s 
lessened the pain, it hasn’t gone away but I can cope with it.” (Q12, Baseline 
Interview)  
A small number of patients who continued to experience pain reported being referred to pain 
management services, whereas others found themselves back in primary care having 
attended multiple appointments without a diagnosis or effective pain management. Although 
criteria for pain management services were unclear one patient reported being referred from 
secondary care and being refused (turned down for funding for a specific more specialist 
item of care):  
“I would have loved to have gone to the pain management in [location’s 
name] that [the dental consultant’s name] suggested but the [name of 
healthcare commissioning body who pays for the treatment] turned me down 
for that.” (Q12, 12M Interview) 
Following secondary care consultation, some described returning to primary care for a 
continuation of treatment suggested in secondary care for example repeat prescriptions. 
Others explained that they were redirected within secondary care after their initial 
consultation in secondary care to another, different, speciality within secondary care: 
“the hospital [then] actually wrote to my GP and I think it was them [the hospital] that 
gave them [the GP] the push and they [the GP] actually sent me for a…., referred me 
to a neurosurgeon.” (Q15, Baseline Interview) 
 
The extent to which patients’ pain was managed varied and did not appear to be related to 
the length of time since it began. A minority of patients were pain free following treatment 
and some reported a reduction in pain while others remained with severe or worsening pain. 
Over time patients reported different behaviours with regard to accessing healthcare. For a 
minority of patients who remained with little pain, they reported no need to seek care again 
unless their level of pain increased or their medication became less effective:  
“I am very close to actually going back now [to, name of primary care 
practitioner], because it’s [the pain] starting [to increase again]… I am going 
to [through] a few bits at the moment with stress and it’s [the pain] coming 
back how it was, and it’s really bad. I can feel it coming back. It [the jaw] 
clicks out of joint and then it hurts, but it’s [the pain] nowhere near as bad as it 
has been, but it’s only getting worse”. (Q18, 12M Interview) 
A group of patients with unmanaged, sometimes severe pain, reported continuing to make 
appointments seeking help for their pain. Some patients had specific objectives for these 
appointments; some attended to see if there were any new treatments on the market, while 
others wanted a specific course of treatment or referral: 
“Now [my] last GP visit that I went to, oh, some months ago, I can’t remember 
when, so obviously I persuaded them to let us take some Voltarol [strong anti-
inflammatory analgesia – generic name diclofenac]” (Q20, Baseline Interview)  
Following inconclusive investigations some described feeling that they had reached the end 
of their medical care:  
“And then it [the pain] was sort of forgotten about because I’d had all that 
[Polypectomy. GP appointment, referral, secondary care appointment, prescription of 
pain medication, MRI] done and everybody just sort of let me drift back into the 
ether.” (Q5, Baseline Interview) 
 
Failure to progress in diagnosis and or treatment 
Whilst patients reported multiple appointments, often with different healthcare professionals, 
a ‘failure to progress’ was a strong theme within the data and related to achieving a 
diagnosis or management of their persistent orofacial pain.  
Few respondents reported being given a diagnosis and/or any successful management at 
their initial appointments in their care pathway. Several respondents described misdiagnosis 
in primary care resulting in unnecessary treatment and further delays in pain management:  
“I was told it [the pain] was [due to] sinus trouble when I first went so I got like a nasal 
spray and it actually made it [the pain] worse.” (Q15, Baseline Interview) 
Initial attempts at management of pain in primary care were reportedly often made without a 
firm diagnosis. Respondents reported a variety of initial management attempts including 
prescriptions of antibiotics or pain medications from GPs, and fitting of dental splints, 
replacement of fillings, extractions, and the prescription of jaw exercises from General 
Dental Practitioners. Sometimes patients reported several consecutive treatments in an 
attempt to find one that was effective with acceptable levels of side effects. This process 
could last for an extended period of time without resulting in any symptomatic relief:  
“when I go [to the GP] it’s just kind of a cycle, try this new medication and come back 
six weeks say when you can tell me if it’s [the pain] improved and if it has improved 
we’ll keep you on it for a bit longer, if it hasn’t we’ll try something else, that’s what’s 
been like for the past two or three years.” (Q7, Baseline Interview) 
A number of patients attributed the fact that they had not received effective management to 
professionals failing to take seriously or prioritise their pain:  
“I think for me the frustration initially was a lot of appointments [with varying primary 
care practitioners] but I wasn’t really getting anything from them because nobody was 
really – well I didn’t feel like they [the Healthcare professionals consulted in primary 
care] were taking the whole situation very seriously”. (Q22, Baseline Interview) 
When pain remained unmanaged this sometimes led to patients questioning the ability of 
their primary care practitioner to provide management of their complaint:  
“I just feel sometime well the GP is really nice, but how many times did she come 
across this [the pain problem and its diagnosis]?” (Q2, Baseline Interview) 
For others, referral to secondary care functioned as a setting in which to conduct diagnostic 
tests such as MRIs or CT scans but following negative results, patients were discharged. On 
several occasions tests ruled out specific conditions but still left patients without a diagnosis. 
Some patients described communication of these results as further evidence of a failure to 
acknowledge their condition on the part of healthcare professionals and a failure to progress:  
“he [GP, following referral for CT scan] thought: ‘Well, there’s nothing wrong’; nothing 
– obviously you haven’t got a tumour; you haven’t got this or that; but I don’t think he 
understood that even though that showed that there wasn’t anything major in those 
respects; that there was still – I still had the same problem [persistent facial pain].” 
(Q19, Baseline Interview)  
Negative diagnostic tests were not always a reassurance and sometimes, rather than being 
relieved patients described disappointment accompanying uncertainty over the cause of their 
pain and a possible treatment:  
“I think I’d rather just see the worst, to be honest. Even if it had said it was cancerous 
or something, at least I would have known, rather than not known.” (Q7, 12M 
Interview)   
Another group, however, despite unmanaged pain, felt that they had little to gain from 
accessing further healthcare and described disengaging with the health service. Some 
attributed this to a failure on the part of the healthcare professionals and the existing care 
pathway:  
“I think they [several different General Dental Practitioners consulted previously] 
didn’t really believe… so partly that, partly ‘cos it [different treatments attempted] 
sometimes made it worse and also ‘cos you know it just wasn’t getting anywhere with 
it I sort of still had the pain but just stopped going.” (Q10, Baseline Interview).  
Although a number of patients who stopped attending appointments felt that healthcare 
professionals were responsible for their lack of pain management, others believed that the 
main problem was the lack of effective treatments available:  
“I don’t really talk about my pain at the doctors much unless I am asked about it 
because there is not a lot of point because what can they say to you, what can they 
say? They can’t say, ‘We got a cure next week, get in a queue and you are at the 
hospital next week.’” (Q11, 12M Interview) 
While many people described frustration with healthcare professionals and the lack of 
progress throughout their care pathway, those who remained with unmanaged pain 
emphasised the importance of healthcare professionals being empathetic, even in the 
absence of being able to offer any effective treatment:  
“That made such a difference, to think that somebody actually cared about you, as a 
person, and not just wanting to get you out of the surgery as quickly as possible. 
Even though she can’t do anything practical, to change the situation, it just made a 
difference to see that she really understood how bad the problem was, and was 
concerned. It does make a big difference as to how you feel.” (Q19, 12M Interview) 
Although in some cases patients described a diagnosis leading to successful treatment, 
diagnosis did not always seem to equate to management of the pain and some without a 
diagnosis described their pain as well managed.  As time progressed, the relevance of a 
diagnosis appeared to change from that of the functional purpose (i.e. to have a label for 
their condition) to one of legitimisation as they became aware of others, or even themselves, 
questioned the physical basis of their pain:  
“I’ve got to admit, my wife suggested this to us [me] as well, and I have thought about 
it, could it be psychological?” (Q20, Baseline Interview) 
 
Impact of unmanaged pain. 
Patients spoke extensively of the impact that unmanaged pain had on multiple areas of their 
life. In addition to medical and dental treatment, ongoing pain management also comprised 
an element of self-management for many patients. For some this consisted of trying to 
identify and avoid triggers and make lifestyle changes, whilst others used home remedies, 
complementary therapies or private medical care. Some felt that these strategies played an 
important role in helping them to manage their persistent orofacial pain and over time 
reported getting better at strategies which they felt led to a decrease in their pain: 
“I think I’m aware of that [trigger for pain], and so if I am very tired or stressed 
I’ll think, “No, I’ll not have any alcohol” or something, just because I know that 
that might have an adverse effect.” (Q17, 12M Interview) 
The impact of remaining with unmanaged pain varied between individuals and appeared to 
be influenced by their personal circumstances and the nature and severity of their pain. The 
sensation of pain and its accompanying symptoms were discussed in detail by patients:  
“the pain is very very uncomfortable but it’s the feeling sick, the sort of not 
being able to co-ordinate your speech, not being able to do anything, not 
being able to smell anything you know the whole thing that surrounds the 
migraine” (Q1, 12M Interview)  
The impact of pain was not limited to the unpleasant sensation and patients described the 
impact on multiple areas of their lives including everyday tasks, psychological well-being 
family life, social activities and work and personal finances. Patients described difficulties 
working while experiencing pain:  
“I was tired because I wasn’t sleeping terribly well I do think it affects my 
performance at work.” (Q16 Baseline Interview) 
 
Fewer individuals reported experiencing pain that would leave them unable to work and for 
others the severity and continuation of their pain and medication side effects were disabling: 
“I don’t do anything. I just haven’t got the energy. The pain takes control over 
your life. You feel so worn out with it that all you want to do is just sleep if you 
can. Sometimes when I take all of the pills, I don’t know what date it is. I 
forget things. I’m just not in control of my own life. If you take all of the pills, 
you’re absolutely a walking zombie and it doesn’t seem to make any 
difference.” (Q12, 12M Interview) 
Although several patients had undergone diagnostic tests, which had ruled out specific 
conditions, the precise cause of their pain remained something that caused concern:  
“Why a diagnosis would help me is because my mind, since 1987, has been, 
shall we say, in a bit of turmoil. I think, “What is happening inside my head? 
Have I got a tumour?” etc., etc. Do you know what I mean? I suppose this is 
the way your mind works, everybody’s does work, but I’ve had to overcome 
this by myself, and with help from my wife as well.” (Q20, 12M Interview) 
 Even patients who had eventually made progress towards management of their pain could 
have continued negative consequences on their lives:  
“I just wish that all these things like the pain therapy that it was all offered 
sooner I would maybe not have lost my job if they could have got the pain 




Patients generally recalled and described fluid and complex care pathways in which they 
visited medical and dental primary care practitioners and medical and dental specialists in a 
range of secondary care settings: neurology, pain clinics, oral surgery, ear nose and throat 
surgery, physiotherapy, ophthalmology, maxillofacial surgery and haematology. Although 
patients were recruited to this study independently from primary and secondary care, the 
complex nature of their pathways meant that this position was often fluid with continual 
movement between care sectors. Several different care pathways were evident in the data, 
but a consistently recurrent theme, was a failure to progress, which spanned diagnosis, 
referral, and treatment in both primary and secondary care.  
  
Discussion 
These data highlight problems with the care pathway from the perspective of a group of 
patients with persistent orofacial pain in the United Kingdom. The major problem appeared 
to be the length of time, which it took for patients to progress from presenting with pain to 
receiving a diagnosis and effective treatment, with some of this sample having received 
neither of these after an extended period of time.  
Many patients described persistence in attending appointments in both primary and 
secondary care in an attempt to access effective treatment. From a patient perspective, 
relationships with healthcare professionals were at times problematic with continued failure 
to manage their pain being attributed to healthcare professionals lack of interest, empathy or 
knowledge.  Previous literature has highlighted similarly problematic relationships from a 
healthcare professional perspective with patients with long term, sometimes medically 
unexplained conditions, who attend frequently and remain dissatisfied being labelled as 
‘Heartsink’ patients (Bligh 1999; O'Dowd 1988). In this sense persistent orofacial pain may 
share some aspects with other painful and/or difficult to diagnosis conditions such as 
Fibromyalgia (Arnold et al. 2008) or Chronic Fatigue Syndrome. Where persistent orofacial 
pain differs from many other chronic illnesses is that the location of the pain means that 
persistent orofacial pain’s care pathways often involve appointments with both medical and 
dental healthcare professionals.  
These repeated appointments described in these qualitative data are also reflected in the 
quantitative data from the same study (Durham et al. 2016), which highlight a large number, 
and consequently high cost, of consultations. These interview data provide some 
explanation for these appointments but also suggest that, despite a high number of 
appointments patients’ pain remains unmanaged for extended periods.  Furthermore the 
longer pain remains unmanaged, the greater the potential for significant impacts on patient’s 
lives. This too is mirrored in the quantitative data from the DEEP study with significant 
impacts on patients’ quality of life that are a similar level to those caused by other chronic 
illnesses such as arthritis (Durham et al. 2015). 
The referral process from primary care seemed to vary greatly between patients, with some 
patients being referred quickly and others waiting for a long period of time. Despite a 
previously reported tendency for General Dental Practitioners to refer to secondary care 
(Aggarwal et al. 2011a; Durham et al. 2007; Peters et al. 2015), there is evidence that 
persistent orofacial pain does not always require specialist diagnosis; Aggarwal et al (2011b) 
suggested that, although there may be knowledge gaps, General Dental Practitioners may 
have sufficient capability to provide a diagnosis and Dworkin et al (2001) also conclude that 
non-specialist management can be effective. Our data also suggests that primary care may 
be an appropriate place to manage some patients, either in isolation or in partnership with 
specialist secondary care dependent on the presenting complaint and comorbidity. In other 
persistent pain conditions there is suggestion that stratified care pathways may be more 
appropriate both in terms of health outcomes and cost savings (Hill et al.) and there may be 
lessons to be learnt from other chronic conditions in the management of persistent orofacial 
pain.  
The majority of those interviewed had taken a long time to receive a diagnosis and some 
were still unable to recall being given a diagnosis despite having experienced pain for a 
number of years. Although patients had initially described the need for a diagnosis in order 
to direct healthcare professionals to appropriate treatment, this may have taken on greater 
importance as their pain remained undiagnosed despite diagnostic tests and multiple 
appointments. For patients where a negative diagnostic test was communicated to them as 
‘good news’ there was a clear discord between how a negative test was perceived by patient 
and the healthcare professional. For some patients a negative test result appeared to mark 
an end-point in healthcare professionals’ efforts to diagnose and treat their pain and 
therefore it seemed to those individuals that a diagnosis was necessary in order to qualify for 
further medical care.  
Previous chronic pain research has highlighted the importance of diagnosis and treatment in 
order for patients to gain legitimacy; the labelling and treatment of their condition is proof of 
their illness (Glenton 2003). The presence of uncertainty from healthcare professionals 
coupled with a failure of tests to provide a diagnosis may serve to ‘disconfirm’ patient’s pain 
as well as prompting others, such as family, work colleagues and employers, to question the 
legitimacy of an ‘invisible’ complaint (Rhodes et al. 1999). Based on a study of people 
suffering from chronic back pain, it has been suggested that the inability of healthcare 
professionals to provide patients with a diagnosis, information or treatment acts to prolong 
the dependency of patients on healthcare professionals (Glenton 2003). This may be 
particularly relevant in primary care where appointments are initiated by the patient rather 
than accessed via referral as are secondary care consultations. Additionally, Durham et al 
(2010) have emphasised the negative effects of the uncertainty that living with undiagnosed 
pain can have.  In orofacial pain, Aggarwal has emphasised the importance of an early 
diagnosis in ensuring contact with the correct healthcare professionals in order to contain 
healthcare resources (Aggarwal et al. 2008). Our data suggest that patients struggle to 
achieve an early diagnosis in the existing care pathway but also highlight a need for 
continued management of their pain with or without a diagnostic label. 
Reflections on Methodology 
This research adds to a limited amount of qualitative research on care pathways in 
persistent orofacial pain and helps to contextualise previous and current cost data within the 
patient experience.  Our sample comprised a heterogeneous group of patients with regard to 
gender, care environments experienced, time in care, origin of persistent orofacial pain and 
diagnosis. In the wider context of the DEEP study, these data act in an explanatory role with 
regard to costs of care and outcomes. Due to the fact that this study is based on a purposive 
sample within a specific geographic area caution needs to be exercised in extrapolating 
these generalising our findings to other localities or other healthcare systems. The data do, 
however, triangulate with other data in the literature pointing to similar difficulties for patients 
with persistent orofacial pain. The constructs patients raised also seem to be stable over the 
timeframe of the longitudinal interviews and there were limited changes, depicted in the data, 
in their perceptions of the care pathway over time. 
As with other qualitative studies we cannot assume that this sample is representative of the 
wider persistent orofacial pain population however, through the use of careful purposive 
sampling we sought to capture and illustrate a depth and breadth of experiences and 
perspectives. In addition, as data collection and analysis progressed we deliberately sought 
out the views of those who may have had a different experience by virtue of their diagnosis, 
gender, age or location. Nearly half of our sample had pain that began more than five years 
prior to the study, which whilst providing an important perspective on care pathways, may 
also have led to recall bias. In conjunction with quantitative data from the DEEP study, these 




Current care pathways do not appear to be meeting patient needs despite indications of 
substantial healthcare resource use. Patients describe being without a diagnosis and 
effective pain management for extended periods of time. Changes to care pathways need to 
ensure that patients receive a timely diagnosis, treatment and referral if necessary and one 
way of achieving this may be through a restructuring of care provision for persistent orofacial 
pain in primary and secondary care. A care pathway that contains a reduction in the number 
of consultations may have the potential to reduce the biopsychosocial effects of pain in 
addition to limiting the number of ineffective healthcare appointments. There is also a need 
for a greater understanding of the role of primary and secondary medical and dental care in 
both short and longer-term management of persistent orofacial pain. Future research should 
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Table 1. Participant Characteristics 
  Number of patients 
(number of patients 
following dropout at 12M) 
Gender Male 5 (4) 
Female 17 (14) 
Reported diagnosis on 
entry to study* 
Temporomandibular Disorder (TMD) 8 (6) 
Trigeminal Neuralgia (TN) 3 (3) 
Persistent Idiopathic Facial Pain 1 (0) 
Peripheral Neuropathy 1 (1) 
Migraine 2 (2) 
No diagnosis 8 (7) 
Age (years) ≤40 4 (4) 
41-49 6 (5) 
50-59 4  (2) 
60-69 6 (5) 
≥70 2 (2) 
Time since pain started ≤ 12 months 3 (2) 
12 months – 5 years  9 (9) 
5-10 years 2 (2) 
≥10 years 8  (5) 
Different healthcare 
professionals seen (n) 
1-4 11 (10) 
5-8 7 (5) 
9-12 4 (3) 




1-20 15 (13) 
21-40 2 (2) 
41-60 4 (2) 
61-80 1 (1) 
*Individuals could have more than one diagnosis. 
 
  
 
 
 
 
 
